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N”-Acetylation is the most frequently occurring 
chemical modification of the (r-NH2 group of eukary- 
otic proteins and was believed until now to be catalyzed 
by a single N”-acetyltransferase. The transfer of an 
acetyl group from acetyl coenzyme A to the a-amino 
group of five NHz-terminal residues (serine, alanine, 
methionine, glycine, and threonine) in proteins ac- 
counts for -95% of acetylated residues. We have found 
that a crude lysate from Saccharomyces cerevisiae 
mutant (aaal) deficient in iV”-acetyltransferase activ- 
ity can effectively transfer an acetyl group to peptides 
containing NHz-terminal methionine but not to serine 
or alanine. This methionine iV”-acetyltransferase has 
been extensively purified, and this purified enzyme 
can selectively transfer an acetyl group to various 
model peptides containing an NH&erminal methionine 
residue and a penultimate aspartyl, asparaginyl, or 
glutamyl residue. Such specificity of N”-acetylation of 
methionine has been previously observed based on the 
analysis of eukaryotic protein sequences (Persson, B., 
Flinta, C., Heijne, G., and Jornvall, H. (1985) Eur. J. 
Biochem. 152, 523-527; Arfin, S. M., and Bradshaw, 
R. A. (1988) Biochemistry 27,7979-7984). The iden- 
tification of this methionine N”-acetyltransferase pro- 
vides an explanation as to why two distinct classes of 
N”-acetylated proteins exist in nature: (i) those whose 
initiator methionine is acetylated and (ii) those whose 
penultimate residue is acetylated after cleavage of the 
initiator methionine. 
W-Acetylation is the major chemical modification of the 
a-amino group of proteins occurring in eukaryotic cells (l-5). 
Narita (6) first demonstrated the presence of an N*-acetyl 
group in the tobacco mosaic virus coat protein, and it is now 
known that 50-80% of soluble eukaryotic protein is N”- 
acetylated (7-9). N*-Acetylation markedly affects the biolog- 
ical activity of proteins and peptides. For example, N”-acety- 
lation has a profound regulatory effect on the biological 
activity of two products of proopiomelanocortin; the opioid 
activity of /3-endorphin is completely suppressed, while the 
melanotropic effect of ol-melanocyte-stimulating hormone is 
markedly increased (lo-12), and in contrast to normal nona- 
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cetylated human hemoglobin, variant human hemoglobin Ra- 
leigh (& valine + acetylalanine) and feline hemoglobin with 
N”-acetylated NHp-terminal residues display a decreased af- 
finity for oxygen and decreased interaction with organic phos- 
phate cofactors (13, 14). Further, the rate of protein turnover 
mediated by the ubiquitin-dependent degradation system de- 
pends on the presence of a free a-amino group at the amino 
terminus of model proteins (15, 16), and this dependence 
indicates that W-acetylation may play a crucial role in imped- 
ing protein turnover. Consequently, iV”-acetylation is impor- 
tant in regulating diverse protein functions. 
The transfer of an acetyl group from acetyl coenzyme A to 
the a-amino group is catalyzed by W-acetyltransferase. Re- 
cently, iV”-acetyltransferase with similar substrate specifici- 
ties were purified from yeast and hen oviduct (17, 18). The 
yeast enzyme is encoded by a single gene (AAA1 (19); also 
called NAT1 (20)), which was disrupted by gene replacement 
to generate a yeast null mutant (-1; also called nut1 ) lacking 
N”-acetyltransferase activity (20, 21). This mutant was spor- 
ulation defective, sensitive to heat shock, and a-type mating 
function defective. An analysis of soluble proteins from the 
aual mutant and wild type yeast strain by two-dimensional 
gel electrophoresis indicated that only 20% of detectable 
soluble proteins in the umzl mutant were electrophoretically 
shifted in a manner expected for proteins lacking an W-acetyl 
group (22). In contrast, approximately 50% of soluble protein 
in yeast is known to be N”-acetylated (9). Therefore, we 
investigated whether additional N*-acetyltransferases might 
be present in the aaal mutant, lacking what we believed to 
be the only yeast W-acetyltransferase. Here, we report the 
identification of another N”-acetyltransferase that selectively 
transfers an acetyl group to peptides containing NHP-terminal 
methionine. 
EXPERIMENTAL PROCEDURES 
Materials-[3H]Acetyl coenzyme A was from Amersham Corp., 
and unlabeled acetyl coenzyme A was from Pharmacia LKB Biotech- 
nology Inc. Reagents and solvents for amino acid analysis and Ready- 
Solv EP scintillation mixtures were obtained from Beckman. SP 
membrane discs were from Cuno Inc. Reagents and solvents for 
protein sequence analysis were from Applied Biosystems. Reagents 
for peptide synthesis were obtained from Applied Biosystems, Inc., 
and solvents for peptide synthesis were from Anachem. Boc-amino 
acids were from Peninsula. All other chemicals were reagent grade or 
better. 
Strains and Media-Yeast strains T3A (MATa his3, leu2, ura3, 
AAAl) and T3A-a (MATa hisd, leu2, ura.3, aanl-1) (21) were used in 
this study. Yeast culture media were prepared, as described by Sher- 
man et al. (23); YPD contained 1% Bacto-yeast extract, 2% Bacto- 
peptone, and 2% glucose. 
Preparation of Yeast Lysates and N”-Acetyltransfera.se Activity 
Assay-Yeast were grown overnight on a rotary shaker at 30 “C, 200 
rpm in YPD medium to Am = 6.0. Yeast crude lysates were prepared, 
and N”-acetyltransferase activity was determined as previously de- 
scribed (17). Aliquots of the lysate were added to 1.5-ml Eppendorf 
tubes containing a reaction mixture of 50 mM HEPES,’ pH 7.4, 150 
mM KCl, 1 mM DTT, 25 @M [3H]acetyl coenzyme A (0.5 &i), and 50 
pM synthetic peptide with an adjusted final volume of 100 ~1. The 
assay mixture was incubated at 30 “C for 30 min. The reaction was 
stopped by adding 0.5 M acetic acid and chilled in an ice bath. The 
reaction samples were filtered through SP membrane discs and then 
1 The abbreviations used are: HEPES, N-2-hydroxyethylpipera- 
zine-N’-2-ethanesulfonic acid; DTT, dithiothreitol; MES, P-(N-mor- 
pholino)ethanesulfonic acid. 
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FIG. 1. Proposed pathway for the co-translational modifi- 
cation of eukaryotic proteins involving methionine aminopep- 
tidase (MAP) and a single N”-acetyltransferase (N”AT), as 
previously proposed by Arfin and Bradshaw (26). MAP re- 
moves the initiator methionine from most but not all proteins, and a 
single N”-acetyltransferase acetylates certain proteins from each 
class. The initiator methionine, penultimate residue, and acetyl group 
at the a-amino group are indicated by M, X, and AC, respectively. 
The nascent polypeptide is indicated (---). The positive (+) and 
negative (-) actions of the enzymes for the protein substrates are 
indicated. 
TABLE I 
N”-Acetylation of various peptide substrates by crude yeast lysates 
from wild type and aaal mutant strains 
The wild type (containing endogenous N”-acetyltransferase activ- 
ity) and the aaal (lacking endogenous N”-acetyltransferase activity) 
strains were T3A and T3A-a, respectively (21). Human adrenocorti- 
eotropic hormone-(l-24), yeast alcohol dehydrogenase-(l-24), and 
human superoxide dismutase-(l-24) have either serine or alanine as 
amino-terminal residues, while proteinase A inhibitor 3 has a methi- 
onine residue. The synthesis of the peptide substrates, the preparation 
of the crude yeast lysates, and the assay of enzyme activity were as 
described under “Experimental Procedures.” The numbers in paren- 
theses refer to the residue numbers, and the letters in parentheses 
specify the amino acid sequence. Data are reported as mean activity 
f SD. (n = 3-5) and are normalized to the activity of the lysate 
(-2.0 enzyme units) toward human adrenocorticotropic hormone-il- 
24) (ACTH-(l-24)). 
Substrate 
(amino acid sequence) 
Activity 
A&U+ aM1- 
% 
ACTH-(l-24) (human) (S-Y- 100 + 5 0 
S-M-E-H-F-R-W-G-K-P-V- 
G-K-K-R-R-P-V-K-V-Y-P) 
Alcohol dehydrogenase I- (l- 102 rt 5 0 
24) (yeast) (S-I-P-E-T-Q-K- 
G-V-I-F-Y-E-S-H-G-K-L-E- 
Y-K-D-I-P) 
Superoxide dismutase-(l-24) 80 t 6 0 
(human) (A-T-K-A-V-C-V- 
L-K-G-D-G-P-V-Q-G-S-I-N- 
F-E-Q-K-E) 
Proteinase A inhibitor 3-(I-24) 75 + 5 80 f 5 
(yeast) (M-N-T-D-Q-Q-K-V- 
S-E-I-F-Q-S-S-K-E-K-L-Q- 
G-D-A-K) 
washed with 0.5 M acetic acid on a Millipore 1225 sampling manifold. 
The partially dried membranes were placed in scintillation mixture 
and counted with a Beckman LS 3801 scintillation counter. One unit 
of activity was deftned as the amount, of enzyme able to transfer 1 
pmol of [3H]acetyl group from [“Hlacetyl coenzyme A to synthetic 
peptide per min under standard enzyme assay conditions defined 
above. 
i’eptide Synthesis and Analysis-Peptides were synthesized on an 
Applied Biosystems model 430A peptide synthesizer and character- 
ized by methods previously described (24). Peptide sequence analysis 
was carried out by using an Applied Biosystems 470A protein Se- 
TABLE II 
Purification of methionine-specific N”-acetyltransferose from S. 
cerevisiae (strain T3A-a) 
Yeast culture (10 x 1 liter) was grown at 30 “C, 200 rpm in YPD 
medium to A600 = 6.0. Yeast crude lysates were prepared, and N”- 
acetyltransferase activity using proteinase A inhibitor 3-(l-24) as 
substrate was determined as previously described (17). The superna- 
tant solution of crude lysates was concentrated to a volume of 10 ml, 
using a PM-30 ultra~ltration membrane, and dialyzed overnight 
against 2 X 2 liters of HDG (20 mM HEPES, pH 7.4,0.5 mM DTT, 
10% (v/v) glycerol, and 0.02% NaNB) buffer containing 0.2 M KCl. 
The dialyzed supernatant fluid was applied to DEAE-Sepharose CL- 
dB (2.5 x 55 cm) equilibrated with HDG buffer containing 0.2 M KC1 
and eluted with same buffer. The fractions (4 ml) containing enzyme 
activity were pooled, concentrated to a volume of 5 ml, dialyzed 
overnight against 2 X 2 liters of HDG buffer containing 0.05 M KCl, 
and then applied to a DE52 cellulose column (2.5 X 55 cm) equili- 
brated in HDG buffer containing 0.05 M KCl. The column was eluted 
with a linear gradient of 0.05 M (250 ml) to 0.5 M (250 ml) KC1 in 
HDG buffer. Fractions (3.5 ml) containing enzyme activity were 
pooled, concentrated to a volume of 2.5 ml, dialyzed overnight against 
2 X 2 liters of MDG (20 mM MES, pH 6.7, 0.5 mM DTT, 10% (v/v) 
glycerol, and 0.02% NaN3) buffer containing 0.05 M KCl, and then 
applied to a CM-52 cellulose column (2.5 x 50 cm) equilibrated in 
MDG buffer containing 0.05 M KCl. The column was eluted with a 
linear gradient of 0.05 M (250 ml) to 0.5 M (250 ml) KC1 in MDG 
buffer. Fractions (3.0 ml) were collected, and the fractions containing 
enzyme activity (at -0.15 M KCl) were pooled, concentrated to a 
volume of 1.0 ml, and applied to a Sepharose CL-6B column (2.0 X 
90 cm) equilibrated with 0.1 M potassium phosphate buffer, pH 7.4, 
0.5 mM DTT, 10% (v/v) glycerol, 0.02% NaNa. The column was 
eluted with the same buffer. Fractions (3.5 ml) containing enzyme 
activity were pooled, concentrated to a volume of 0.5 ml, and applied 
to a hydroxylapatite (Bio-Rad) column (2.0 X 15 cm) equilibrated 
with 0.1 M potassium phosphate buffer, pH 7.4, 0.5 mM DTT, 10% 
(v/v) glycerol, 0.02% NaNa. The column was &ted with a linear 
gradient of 0.1 M (100 ml) to 0.6 M (100 ml) potassium phosphate 
buffer, pH 7.4, containing 0.5 mM DTT, 10% (v/v) glycerol, 0.02% 
NaN$. Fractions (2.0 ml) were collected, and the fractions containing 
enzyme activity (at -0.45 M KH*POJ were pooled and concentrated 
to a volume of 0.5 ml. Protein was determined br the Bradford assay 
(Bio-Rad) (33) with bovine serum albumin as tge standard. 
SkP Activity Protein 
Specific Purifi- 
activity cation “‘ld 
units w units/nag -fold % 
1. Crude extract 6400 2200 2.9 1.0 100 
2. DEAE-Sepharose 3760 410 9.2 3.2 59 
3. DE52-cellulose 2450 110 22.3 7.7 38 
4. CMBZ-cellulose 1400 2.2 636 219 22 
5. Sepharose CL-6B 940 0.8 1180 407 15 
6. Hydroxylapatite 380 0.04 9500 3280 6 
quencer and an Applied Biosystems 120A phenylthiohydantoin ana- 
lyzer (25). 
RESULTS AND DISCUSSION 
Two distinct classes of N”-acetylated proteins exist: (i) 
those for which the penultimate residue is acetylated after 
cleavage of the initiator methionine and (ii) those for which 
the initiator methionine is acetylated (26) (Fig. 1). Since the 
peptide substrates used previously in the enzyme assay for 
the AAAI-encoded N”-acetyltransferase contained either 
serine or alanine as NHP-terminal residues (17), we again used 
these substrates to assay crude lysates from the ma1 mutant 
and wild type (~~) yeast strains (Table If. Although it was 
expected that only one ~~-acetyltransferase would be respon- 
sible for transferring an acetyl group to the a-amino group of 
proteins capable of being N”-acetylated (l-5), we assayed for 
the presence of a methionine W-acetyltransferase, since we 
assumed that if there were additional iV‘“-acetyltransferases, 
one specific for methionine might exist (Fig. 1). Using a 
peptide substrate that mimicked the NH, terminus of the 
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FIG. 1. Proposed pathway for the co-translational modifi- 
cation of eukaryotic proteins involving methionine aminopep- 
tidase (MAP) and a single N”-acetyltransferase (N”AT), as 
previously proposed by Arfin and Bradshaw (26). MAP re- 
moves the initiator methionine from most but not all proteins, and a 
single N”-acetyltransferase acetylates certain proteins from each 
class. The initiator methionine, penultimate residue, and acetyl group 
at the a-amino group are indicated by M, X, and AC, respectively. 
The nascent polypeptide is indicated (---). The positive (+) and 
negative (-) actions of the enzymes for the protein substrates are 
indicated. 
TABLE I 
N”-Acetylation of various peptide substrates by crude yeast lysates 
from wild type and aaal mutant strains 
The wild type (containing endogenous N”-acetyltransferase activ- 
ity) and the aaal (lacking endogenous N”-acetyltransferase activity) 
strains were T3A and T3A-a, respectively (21). Human adrenocorti- 
eotropic hormone-(l-24), yeast alcohol dehydrogenase-(l-24), and 
human superoxide dismutase-(l-24) have either serine or alanine as 
amino-terminal residues, while proteinase A inhibitor 3 has a methi- 
onine residue. The synthesis of the peptide substrates, the preparation 
of the crude yeast lysates, and the assay of enzyme activity were as 
described under “Experimental Procedures.” The numbers in paren- 
theses refer to the residue numbers, and the letters in parentheses 
specify the amino acid sequence. Data are reported as mean activity 
f SD. (n = 3-5) and are normalized to the activity of the lysate 
(-2.0 enzyme units) toward human adrenocorticotropic hormone-il- 
24) (ACTH-(l-24)). 
Substrate 
(amino acid sequence) 
Activity 
A&U+ aM1- 
% 
ACTH-(l-24) (human) (S-Y- 100 + 5 0 
S-M-E-H-F-R-W-G-K-P-V- 
G-K-K-R-R-P-V-K-V-Y-P) 
Alcohol dehydrogenase I- (l- 102 rt 5 0 
24) (yeast) (S-I-P-E-T-Q-K- 
G-V-I-F-Y-E-S-H-G-K-L-E- 
Y-K-D-I-P) 
Superoxide dismutase-(l-24) 80 t 6 0 
(human) (A-T-K-A-V-C-V- 
L-K-G-D-G-P-V-Q-G-S-I-N- 
F-E-Q-K-E) 
Proteinase A inhibitor 3-(I-24) 75 + 5 80 f 5 
(yeast) (M-N-T-D-Q-Q-K-V- 
S-E-I-F-Q-S-S-K-E-K-L-Q- 
G-D-A-K) 
washed with 0.5 M acetic acid on a Millipore 1225 sampling manifold. 
The partially dried membranes were placed in scintillation mixture 
and counted with a Beckman LS 3801 scintillation counter. One unit 
of activity was deftned as the amount, of enzyme able to transfer 1 
pmol of [3H]acetyl group from [“Hlacetyl coenzyme A to synthetic 
peptide per min under standard enzyme assay conditions defined 
above. 
i’eptide Synthesis and Analysis-Peptides were synthesized on an 
Applied Biosystems model 430A peptide synthesizer and character- 
ized by methods previously described (24). Peptide sequence analysis 
was carried out by using an Applied Biosystems 470A protein Se- 
TABLE II 
Purification of methionine-specific N”-acetyltransferose from S. 
cerevisiae (strain T3A-a) 
Yeast culture (10 x 1 liter) was grown at 30 “C, 200 rpm in YPD 
medium to A600 = 6.0. Yeast crude lysates were prepared, and N”- 
acetyltransferase activity using proteinase A inhibitor 3-(l-24) as 
substrate was determined as previously des ribed (17). The superna-
tant solution of crude lysates wa  concentrated to a volume of 10 ml, 
using a PM-30 ultra~ltration membrane, and dialyzed overnight 
against 2 X 2 liters of HDG 20 mM HEPES, pH 7.4,0.5 mM DTT, 
10% (v/v) glycerol, and 0.02% NaNB) buffer containing 0.2 M KCl.
The dialyzed sup rnatant fluid was a pli d to DEAE-Sepharose CL- 
dB (2.5 x 55 cm) equilibrated with HDG buffer containing 0.2 M KC1 
and eluted with same buffer. The fractions (4 ml) containing enzyme 
activity were pooled, conce trated to a volum  of 5 ml, dialyz d
overnight against 2 X 2 liters of H G buffer c ntaining 0.05 M KCl, 
and then applied to a DE52 cellulose column (2.5 X 55 cm) equili- 
brated i  HDG buffer containing 0.05 M KCl. The column was luted 
with a linear gradient of 0.05 M (250 ml) to 0.5 M (250 ml) KC1 in 
HDG buffer. Fractions (3.5 ml) containing enzyme activity were 
pooled, concentrated to a volume of 2.5 ml, dialyzed overnight against 
2 X 2 liters of MDG (20 mM MES, pH 6.7, 0.5 mM DTT, 10% (v/v) 
glycerol, and 0.02% NaN3) buffer containing 0.05 M KCl, and then 
applied to a CM-52 cellulose column (2.5 x 50 cm) equilibrated in 
MDG buffer containing 0.05 M KCl. The column was eluted with a 
linear gradient of 0.05 M (250 ml) to 0.5 M (250 ml) KC1 in MDG 
buffer. Fractions (3.0 ml) were collected, and the fractions containing 
enzyme activity (at -0.15 M KCl) were pooled, concentrated to a 
volume of 1.0 ml, and applied to a Sepharose CL-6B column (2.0 X 
90 cm) equilibrated with 0.1 M potassium phosphate buffer, pH 7.4, 
0.5 mM DTT, 10% (v/v) glycerol, 0.02% NaNa. The column was 
eluted with the same buff r. Fractions (3.5 ml) containing enzyme 
activity were pooled, concentrated to a volume of 0.5 ml, and applied 
to a hydroxylapatite (Bio-Rad) column (2.0 X 15 cm) equilibrated 
with 0.1 M potassium phosphate buffer, pH 7.4, 0.5 mM DTT, 10% 
(v/v) glycerol, 0.02% NaNa. The column was &ted with a linear 
gradient of 0.1 M (100 ml) to 0.6 M (100 ml) potassium phosphate 
buffer, pH 7.4, containing 0.5 mM DTT, 10% (v/v) glycerol, 0.02% 
NaN$. Fractions (2.0 ml) were collected, and the fractions containing 
enzyme activity (at -0.45 M KH*POJ were pooled and concentrated 
to a volume of 0.5 ml. Protein was determined br the Bradford assay 
(Bio-Rad) (33) with bovine serum albumin as tge standard. 
SkP Activity Protein 
Specific Purifi- 
activity cation “‘ld 
units w units/nag -fold % 
1. Crude extract 6400 2200 2.9 1.0 100 
2. DEAE-Sepharose 3760 410 9.2 3.2 59 
3. DE52-cellulose 2450 110 22.3 7.7 38 
4. CMBZ-cellulose 1400 2.2 636 219 22 
5. Sepharose CL-6B 940 0.8 1180 407 15 
6. Hydroxylapatite 380 0.04 9500 3280 6 
quencer and an Applied Biosystems 120A phenylthiohydantoin ana- 
lyzer (25). 
RESULTS AND DISCUSSION 
Two distinct classes of N”-acetylated proteins exist: (i) 
those for which the penultimate residue is acetylated after 
cleavage of the initiator methionine and (ii) those for which 
the initiator methionine is acetylated (26) (Fig. 1). Since the 
peptide substrates used previously in the enzyme assay for 
the AAAI-encoded N”-acetyltransferase contained either 
serine or alanine as NHP-terminal residues (17), we again used 
these substrates to assay crude lysates from the ma1 mutant 
and wild type (~~) yeast strains (Table If. Although it was 
expected that only one ~~-acetyltransferase would be respon- 
sible for transferring an acetyl group to the a-amino group of 
proteins capable of being N”-acetylated (l-5), we assayed for 
the presence of a methionine W-acetyltransferase, since we 
assumed that if there were additional iV‘“-acetyltransferases, 
one specific for methionine might exist (Fig. 1). Using a 
peptide substrate that mimicked the NH, terminus of the 
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FIG. 1. Proposed pathway for the co-translational modifi- 
cation of eukaryotic proteins involving methionine aminopep- 
tidase (MAP) and a single N”-acetyltransferase (N”AT), as 
previously proposed by Arfin and Bradshaw (26). MAP re- 
moves the initiator methionine from most but not all proteins, and a 
single N”-acetyltransferase acetylates certain proteins from each 
class. The initiator methionine, penultimate residue, and acetyl group 
at the a-amino group are indicated by M, X, and AC, respectively. 
The nascent polypeptide is indicated (---). The positive (+) and 
negative (-) actions of the enzymes for the protein substrates are 
indicated. 
TABLE I 
N”-Acetylation of various peptide substrates by crude yeast lysates 
from wild type and aaal mutant strains 
The wild type (containing endogenous N”-acetyltransferase activ- 
ity) and the aaal (lacking endogenous N”-acetyltransferase activity) 
strains were T3A and T3A-a, respectively (21). Human adrenocorti- 
eotropic hormone-(l-24), yeast alcohol dehydrogenase-(l-24), and 
human superoxide dismutase-(l-24) have either serine or alanine as 
amino-terminal residues, while proteinase A inhibitor 3 has a methi- 
onine residue. The synthesis of the peptide substrates, the preparation 
of the crude yeast lysates, and the assay of enzyme activity were as 
described under “Experimental Procedures.” The numbers in paren- 
theses refer to the residue numbers, and the letters in parentheses 
specify the amino acid sequence. Data are reported as mean activity 
f SD. (n = 3-5) and are normalized to the activity of the lysate 
(-2.0 enzyme units) toward human adrenocorticotropic hormone-il- 
24) (ACTH-(l-24)). 
Substrate 
(amino acid sequence) 
Activity 
A&U+ aM1- 
% 
ACTH-(l-24) (human) (S-Y- 100 + 5 0 
S-M-E-H-F-R-W-G-K-P-V- 
G-K-K-R-R-P-V-K-V-Y-P) 
Alcohol dehydrogenase I- (l- 102 rt 5 0 
24) (yeast) (S-I-P-E-T-Q-K- 
G-V-I-F-Y-E-S-H-G-K-L-E- 
Y-K-D-I-P) 
Superoxide dismutase-(l-24) 80 t 6 0 
(human) (A-T-K-A-V-C-V- 
L-K-G-D-G-P-V-Q-G-S-I-N- 
F-E-Q-K-E) 
Proteinase A inhibitor 3-(I-24) 75 + 5 80 f 5 
(yeast) (M-N-T-D-Q-Q-K-V- 
S-E-I-F-Q-S-S-K-E-K-L-Q- 
G-D-A-K) 
washed with 0.5 M acetic acid on a Millipore 1225 sampling manifold. 
The partially dried membranes were placed in scintillation mixture 
and counted with a Beckman LS 3801 scintillation counter. One unit 
of activity was deftned as the amount, of enzyme able to transfer 1 
pmol of [3H]acetyl group from [“Hlacetyl coenzyme A to synthetic 
peptide per min under standard enzyme assay conditions defined 
above. 
i’eptide Synthesis and Analysis-Peptides were synthesized on an 
Applied Biosystems model 430A peptide synthesizer and character- 
ized by methods previously described (24). Peptide sequence analysis 
was carried out by using an Applied Biosystems 470A protein Se- 
TABLE II 
Purification of methionine-specific N”-acetyltransferose from S. 
cerevisiae (strain T3A-a) 
Yeast culture (10 x 1 liter) was grown at 30 “C, 200 rpm in YPD 
medium to A600 = 6.0. Yeast crude lysates were prepared, and N”- 
acetyltransferase activity using proteinase A inhibitor 3-(l-24) as 
substrate was determined as previously described (17). The superna- 
tant solution of crude lysates was concentrated to a volume of 10 ml, 
using a PM-30 ultra~ltration membrane, and dialyzed overnight 
against 2 X 2 liters of HDG (20 mM HEPES, pH 7.4,0.5 mM DTT, 
10% (v/v) glycerol, and 0.02% NaNB) buffer containing 0.2 M KCl. 
The dialyzed supernatant fluid was applied to DEAE-Sepharose CL- 
dB (2.5 x 55 cm) equilibrated with HDG buffer containing 0.2 M KC1 
and eluted with same buffer. The fractions (4 ml) containing enzyme 
activity were pooled, concentrated to a volume of 5 ml, dialyzed 
overnight against 2 X 2 liters of HDG buffer containing 0.05 M KCl, 
and then applied to a DE52 cellulose column (2.5 X 55 cm) equili- 
brated in HDG buffer containing 0.05 M KCl. The column was eluted 
with a linear gradient of 0.05 M (250 ml) to 0.5 M (250 ml) KC1 in 
HDG buffer. Fractions (3.5 ml) containing enzyme activity were 
pooled, concentrated to a volume of 2.5 ml, dialyzed overnight against 
2 X 2 liters of MDG (20 mM MES, pH 6.7, 0.5 mM DTT, 10% (v/v) 
glycerol, and 0.02% NaN3) buffer containing 0.05 M KCl, and then 
applied to a CM-52 cellulose column (2.5 x 50 cm) equilibrated in 
MDG buffer containing 0.05 M KCl. The column was eluted with a 
linear gradient of 0.05 M (250 ml) to 0.5 M (250 ml) KC1 in MDG 
buffer. Fractions (3.0 ml) were collected, and the fractions containing 
enzyme activity (at -0.15 M KCl) were pooled, concentrated to a 
volume of 1.0 ml, and applied to a Sepharose CL-6B column (2.0 X 
90 cm) equilibrated with 0.1 M potassium phosphate buffer, pH 7.4, 
0.5 mM DTT, 10% (v/v) glycerol, 0.02% NaNa. The column was 
eluted with the same buffer. Fractions (3.5 ml) containing enzyme 
activity were pooled, concentrated to a volume of 0.5 ml, and applied 
to a hydroxylapatite (Bio-Rad) column (2.0 X 15 cm) equilibrated 
with 0.1 M potassium phosphate buffer, pH 7.4, 0.5 mM DTT, 10% 
(v/v) glycerol, 0.02% NaNa. The column was &ted with a linear 
gradient of 0.1 M (100 ml) to 0.6 M (100 ml) potassium phosphate 
buffer, pH 7.4, containing 0.5 mM DTT, 10% (v/v) glycerol, 0.02% 
NaN$. Fractions (2.0 ml) were collected, and the fractions containing 
enzyme activity (at -0.45 M KH*POJ were pooled and concentrated 
to a volume of 0.5 ml. Protein was determined br the Bradford assay 
(Bio-Rad) (33) with bovine serum albumin as tge standard. 
SkP Activity Protein 
Specific Purifi- 
activity cation “‘ld 
units w units/nag -fold % 
1. Crude extract 6400 2200 2.9 1.0 100 
2. DEAE-Sepharose 3760 410 9.2 3.2 59 
3. DE52-cellulose 2450 110 22.3 7.7 38 
4. CMBZ-cellulose 1400 2.2 636 219 22 
5. Sepharose CL-6B 940 0.8 1180 407 15 
6. Hydroxylapatite 380 0.04 9500 3280 6 
quencer and an Applied Biosystems 120A phenylthiohydantoin ana- 
lyzer (25). 
RESULTS AND DISCUSSION 
Two distinct classes of N”-acetylated proteins exist: (i) 
those for which the penultimate residue is acetylated after 
cleavage of the initiator methionine and (ii) those for which 
the initiator methionine is acetylated (26) (Fig. 1). Since the 
peptide substrates used previously in the enzyme assay for 
the AAAI-encoded N”-acetyltransferase contained either 
serine or alanine as NHP-terminal residues (17), we again used 
these substrates to assay crude lysates from the ma1 mutant 
and wild type (~~) yeast strains (Table If. Although it was 
expected that only one ~~-acetyltransferase would be respon- 
sible for transferring an acetyl group to the a-amino group of 
proteins capable of being N”-acetylated (l-5), we assayed for 
the presence of a methionine W-acetyltransferase, since we 
assumed that if there were additional iV‘“-acetyltransferases, 
one specific for methionine might exist (Fig. 1). Using a 
peptide substrate that mimicked the NH, terminus of the 
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FIG. 1. Proposed pathway for the co-translational modifi- 
cation of eukaryotic proteins involving methionine aminopep- 
tidase (MAP) and a single N”-acetyltransferase (N”AT), as 
previously proposed by Arfin and Bradshaw (26). MAP re- 
moves the initiator methionine from most but not all proteins, and a 
single N”-acetyltransferase acetylates certain proteins from each 
class. The initiator methionine, penultimate residue, and acetyl group 
at the a-amino group are indicated by M, X, and AC, respectively. 
The nascent polypeptide is indicated (---). The positive (+) and 
negative (-) actions of the enzymes for the protein substrates are 
indicated. 
TABLE I 
N”-Acetylation of various peptide substrates by crude yeast lysates 
from wild type and aaal mutant strains 
The wild type (containing endogenous N”-acetyltransferase activ- 
ity) and the aaal (lacking endogenous N”-acetyltransferase activity) 
strains were T3A and T3A-a, respectively (21). Human adrenocorti- 
eotropic hormone-(l-24), yeast alcohol dehydrogenase-(l-24), and 
human superoxide dismutase-(l-24) have either serine or alanine as 
amino-terminal residues, while proteinase A inhibitor 3 has a methi- 
onine residue. The synthesis of the peptide substrates, the preparation 
of the crude yeast lysates, and the assay of enzyme activity were as 
described under “Experimental Procedures.” The numbers in paren- 
theses refer to the residue numbers, and the letters in parentheses 
specify the amino acid sequence. Data are reported as mean activity 
f SD. (n = 3-5) and are normalized to the activity of the lysate 
(-2.0 enzyme units) toward human adrenocorticotropic hormone-il- 
24) (ACTH-(l-24)). 
Substrate 
(amino acid sequence) 
Activity 
A&U+ aM1- 
% 
ACTH-(l-24) (human) (S-Y- 100 + 5 0 
S-M-E-H-F-R-W-G-K-P-V- 
G-K-K-R-R-P-V-K-V-Y-P) 
Alcohol dehydrogenase I- (l- 102 rt 5 0 
24) (yeast) (S-I-P-E-T-Q-K- 
G-V-I-F-Y-E-S-H-G-K-L-E- 
Y-K-D-I-P) 
Superoxide dismutase-(l-24) 80 t 6 0 
(human) (A-T-K-A-V-C-V- 
L-K-G-D-G-P-V-Q-G-S-I-N- 
F-E-Q-K-E) 
Proteinase A inhibitor 3-(I-24) 75 + 5 80 f 5 
(yeast) (M-N-T-D-Q-Q-K-V- 
S-E-I-F-Q-S-S-K-E-K-L-Q- 
G-D-A-K) 
washed with 0.5 M acetic acid on a Millipore 1225 sampling manifold. 
The partially dried membranes were placed in scintillation mixture 
and counted with a Beckman LS 3801 scintillation counter. One unit 
of activity was deftned as the amount, of enzyme able to transfer 1 
pmol of [3H]acetyl group from [“Hlacetyl coenzyme A to synthetic 
peptide per min under standard enzyme assay conditions defined 
above. 
i’eptide Synthesis and Analysis-Peptides were synthesized on an 
Applied Biosystems model 430A peptide synthesizer and character- 
ized by methods previously described (24). Peptide sequence analysis 
was carried out by using an Applied Biosystems 470A protein Se- 
TABLE II 
Purification of methionine-specific N”-acetyltransferose from S. 
cerevisiae (strain T3A-a) 
Yeast culture (10 x 1 liter) was grown at 30 “C, 200 rpm in YPD 
medium to A600 = 6.0. Yeast crude lysates were prepared, and N”- 
acetyltransferase activity using proteinase A inhibitor 3-(l-24) as 
substrate was determined as previously described (17). The superna- 
tant solution of crude lysates was concentrated to a volume of 10 ml, 
using a PM-30 ultra~ltration membrane, and dialyzed overnight 
against 2 X 2 liters of HDG (20 mM HEPES, pH 7.4,0.5 mM DTT, 
10% (v/v) glycerol, and 0.02% NaNB) buffer containing 0.2 M KCl. 
The dialyzed supernatant fluid was applied to DEAE-Sepharose CL- 
dB (2.5 x 55 cm) equilibrated with HDG buffer containing 0.2 M KC1 
and eluted with same buffer. The fractions (4 ml) containing enzyme 
activity were pooled, concentrated to a volume of 5 ml, dialyzed 
overnight against 2 X 2 liters of HDG buffer containing 0.05 M KCl, 
and then applied to a DE52 cellulose column (2.5 X 55 cm) equili- 
brated in HDG buffer containing 0.05 M KCl. The column was eluted 
with a linear gradient of 0.05 M (250 ml) to 0.5 M (250 ml) KC1 in 
HDG buffer. Fractions (3.5 ml) containing enzyme activity were 
pooled, concentrated to a volume of 2.5 ml, dialyzed overnight against 
2 X 2 liters of MDG (20 mM MES, pH 6.7, 0.5 mM DTT, 10% (v/v) 
glycerol, and 0.02% NaN3) buffer containing 0.05 M KCl, and then 
applied to a CM-52 cellulose column (2.5 x 50 cm) equilibrated in 
MDG buffer containing 0.05 M KCl. The column was eluted with a 
linear gradient of 0.05 M (250 ml) to 0.5 M (250 ml) KC1 in MDG 
buffer. Fractions (3.0 ml) were collected, and the fractions containing 
enzyme activity (at -0.15 M KCl) were pooled, concentrated to a 
volume of 1.0 ml, and applied to a Sepharose CL-6B column (2.0 X 
90 cm) equilibrated with 0.1 M potassium phosphate buffer, pH 7.4, 
0.5 mM DTT, 10% (v/v) glycerol, 0.02% NaNa. The column was 
eluted with the same buffer. Fractions (3.5 ml) containing enzyme 
activity were pooled, concentrated to a volume of 0.5 ml, and applied 
to a hydroxylapatite (Bio-Rad) column (2.0 X 15 cm) equilibrated 
with 0.1 M potassium phosphate buffer, pH 7.4, 0.5 mM DTT, 10% 
(v/v) glycerol, 0.02% NaNa. The column was &ted with a linear 
gradient of 0.1 M (100 ml) to 0.6 M (100 ml) potassium phosphate 
buffer, pH 7.4, containing 0.5 mM DTT, 10% (v/v) glycerol, 0.02% 
NaN$. Fractions (2.0 ml) were collected, and the fractions containing 
enzyme activity (at -0.45 M KH*POJ were pooled and concentrated 
to a volume of 0.5 ml. Protein was determined br the Bradford assay 
(Bio-Rad) (33) with bovine serum albumin as tge standard. 
SkP Activity Protein 
Specific Purifi- 
activity cation “‘ld 
units w units/nag -fold % 
1. Crude extract 6400 2200 2.9 1.0 100 
2. DEAE-Sepharose 3760 410 9.2 3.2 59 
3. DE52-cellulose 2450 110 22.3 7.7 38 
4. CMBZ-cellulose 1400 2.2 636 219 22 
5. Sepharose CL-6B 940 0.8 1180 407 15 
6. Hydroxylapatite 380 0.04 9500 3280 6 
quencer and an Applied Biosystems 120A phenylthiohydantoin ana- 
lyzer (25). 
RESULTS AND DISCUSSION 
Two distinct classes of N”-acetylated proteins exist: (i) 
those for which the penultimate residue is acetylated after 
cleavage of the initiator methionine and (ii) those for which 
the initiator methionine is acetylated (26) (Fig. 1). Since the 
peptide substrates used previously in the enzyme assay for 
the AAAI-encoded N”-acetyltransferase contained either 
serine or alanine as NHP-terminal residues (17), we again used 
these substrates to assay crude lysates from the ma1 mutant 
and wild type (~~) yeast strains (Table If. Although it was 
expected that only one ~~-acetyltransferase would be respon- 
sible for transferring an acetyl group to the a-amino group of 
proteins capable of being N”-acetylated (l-5), we assayed for 
the presence of a methionine W-acetyltransferase, since we 
assumed that if there were additional iV‘“-acetyltransferases, 
one specific for methionine might exist (Fig. 1). Using a 
peptide substrate that mimicked the NH, terminus of the 
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FIG. 1. Proposed pathway for the co-translational modifi- 
cation of eukaryotic proteins involving methionine aminopep- 
tidase (MAP) and a single N”-acetyltransferase (N”AT), as 
previously proposed by Arfin and Bradshaw (26). MAP re- 
moves the initiator methionine from most but not all proteins, and a 
single N”-acetyltransferase acetylates certain proteins from each 
class. The initiator methionine, penultimate residue, and acetyl group 
at the a-amino group are indicated by M, X, and AC, respectively. 
The nascent polypeptide is indicated (---). The positive (+) and 
negative (-) actions of the enzymes for the protein substrates are 
indicated. 
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theses refer to the residue numbers, and the letters in parentheses 
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f SD. (n = 3-5) and are normalized to the activity of the lysate 
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Substrate 
(amino acid sequence) 
Activity 
A&U+ aM1- 
% 
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buffer. Fractions (3.0 ml) were collected, and the fractions containing 
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(v/v) glycerol, 0.02% NaNa. The column was &ted with a linear 
gradient of 0.1 M (100 ml) to 0.6 M (100 ml) potassium phosphate 
buffer, pH 7.4, containing 0.5 mM DTT, 10% (v/v) glycerol, 0.02% 
NaN$. Fractions (2.0 ml) were collected, and the fractions containing 
enzyme activity (at -0.45 M KH*POJ were pooled and concentrated 
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(Bio-Rad) (33) with bovine serum albumin as tge standard. 
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proteins capable of being N”-acetylated (l-5), we assayed for 
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TABLE III 
N”-Acetylation of uariow NH2-terminal methionine-containing peptide substrates 
The synthesis of the peptide substrates and the assay of enzyme activity were as described under “Experimental 
Procedures.” The methionine N”-acetyltransferase was purified as described in Table II. The numbers in paren- 
theses refer to the residue numbers, and the letters in parentheses refer to the amino acid sequence. Data are 
reported as mean activity + S.D. (n = 3-5) an d are normalized to the activity of the enzyme (-4.0 enzyme units) 
toward yeast proteinase A inhibitor 3. 
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Substrate 
(amino acid sequence) Activity 
Proteinase A inhibitor 3-(1-24) (yeast) (M-N-T-D-Q-Q-K-V-S-E-I-F-Q-S-S-K-E-K-L-Q-G-D-A-K) 
[Met-‘]Actin-(l-24) (yeast) (M-D-S-E-V-A-A-L-V-I-D-N-G-S-G-M-C-K-A-G-F-A-G-D) 
Protein-tyrosine-phosphatase-(l-24) (human) (M-E-M-E-K-E-F-E-Q-I-D-K-S-G-S-W-A-A-I-Y-Q-D-I-R) 
[Met-‘Asp’]Iso-l-cytochrome c-(1-24) (yeast) (M-D-E-F-K-A-G-S-A-K-K-G-A-T-L-F-K-T-R-C-L-Q-C-H) 
[Met-‘]Iso-l-cytochrome c-(1-24) (yeast) (M-T-E-F-K-A-G-S-A-K-K-G-A-T-L-F-K-T-R-C-L-Q-C-H) 
[Met-‘Ala’]Iso-l-cytochrome c-(1-24) (yeast) (M-A-E-F-K-A-G-S-A-K-K-G-A-T-L-F-K-T-R-C-L-Q-C-H) 
[Met-‘Leu’]Iso-l-cytochrome c-(1-24) (yeast) (M-L-E-F-K-A-G-S-A-K-K-G-A-T-L-F-K-T-R-C-L-Q-C-H) 
[Met’]Alcohol dehydrogenase I-(1-24) (yeast) (M-I-P-E-T-Q-K-G-V-I-F-Y-E-S-H-G-K-L-E-Y-K-D-I-P) 
% 
100 + 5 
65 + 5 
56 f 5 
75 f 5 
0 
0 
0 
0 
Met-N=AT 
+ 
MAP 
+ 
+ 
ti 
Ac.X-- Ac.X-- x--... 
FIG. 2. A, proposed pathway for the co-translational modification of eukaryotic proteins mediated by methionine 
NO-acetyltransferase (Met-PAT), methionine aminopeptidase (MAP), and NO-acetyltransferase (N”-AT). J3, 
alternative pathway involving a single N”-acetyltransferase acting at two different stages of acetylation and acyl- 
amino acid hydrolyase (AAH), as previously proposed by Wold (3). This pathway does not require the action of 
methionine aminopeptidase. The symbols are as indicated in Fig. 1. 
only yeast protein in the SwissProt protein sequence data 
base known to contain an N”-acetylated methionine residue, 
proteinase A inhibitor 3 (27), we observed that crude lysates 
from both the aaal mutant and the AAAl strain were capable 
of acetylating this substrate, although, as expected, the crude 
lysate from the aaal mutant was incapable of acetylating the 
peptide substrates containing serine or alanine as amino- 
terminal residues (Table I). These data demonstrate that a 
methionine-specific N”-acetyltransferase exists. The methio- 
nine-specific N”-acetyltransferase is not a mutagenized form 
of NO-acetyltransferase, since methionine-specific N”-acetyl- 
transferase and N”-acetyltransferase both exist in the wild 
type T3A strain and can be well separated by DE52-cellulose 
chromatography (eluting at 50 and 200 mM KCl, respectively) 
(data not shown). 
From an analysis of eukaryotic protein sequences, it has 
been previously demonstrated that five amino acid residues 
(Le. alanine, serine, methionine, glycine, and threonine) ac- 
count for 95% of all acetylated residues in eukaryotic proteins 
and that N”-acetylated methionine is invariably followed by 
aspartic acid, glutamic acid, or asparagine (28, 29). Therefore, 
we synthesized a series of peptide substrates mimicking var- 
ious iso-1-cytochrome c mutant proteins (previously estab- 
lished to be N”-acetylated or to contain a free a-amino group) 
(30)), human placenta protein-tyrosine-phosphatase (31), as 
well as an actin precursor known to be N”-acetylated (2, 32). 
Each substrate contains and NH2-terminal methionine and 
asparagine, aspartic acid, glutamic acid, threonine, alanine, 
leucine, or isoleucine as the penultimate residue. As shown in 
Table II, we also extensively purified (3280-fold) this methi- 
onine NO-acetyltransferase from Saccharomyces cereuisiae. By 
using this enzyme and synthetic peptides, we found that N”- 
acetylation of methionine occurs only for substrates contain- 
ing asparagine, aspartic acid, or glutamic acid as the penulti- 
mate residue (Table III). Furthermore, none of the yeast 
alcohol dehydrogenase I-(1-24) peptide variants, made with 
each of the 20 amino acids at the first amino acid position, 
can be acetylated by methionine N”-acetyltransferase (data 
not shown), although 9 of these 20 yeast alcohol dehydrogen- 
ase I-(1-24) variants can be acetylated by N”-acetyltransfer- 
ase.’ 
What might be the role for a methionine N”-acetyltransfer- 
ase in protein synthesis? One possibility is that NO-acetylation 
of methionine-containing proteins (accounting for 5-6% of 
acetylated proteins in eukaryotic cells (28)) is required to be 
highly specific to subserve important biological functions, 
’ F.-J. S. Lee, L.-W. Lin, and J. A. Smith, manuscript in prepara- 
tion. 
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